China Universal Asset Management Company’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
17,282
+161
| +0.9% | +$1.51K | 0.02% | 329 |
|
|
2025
Q1 | $210K | Sell |
17,121
-978
| -5% | -$12K | 0.02% | 310 |
|
|
2024
Q4 | $239K | Buy |
18,099
+1,732
| +11% | +$22.9K | 0.02% | 315 |
|
|
2024
Q3 | $315K | Buy |
16,367
+6,383
| +64% | +$123K | 0.03% | 265 |
|
|
2024
Q2 | $205K | Sell |
9,984
-6,354
| -39% | -$130K | 0.03% | 239 |
|
|
2024
Q1 | $389K | Buy |
16,338
+8,280
| +103% | +$197K | 0.05% | 207 |
|
|
2023
Q4 | $174K | Buy |
8,058
+6,276
| +352% | +$136K | 0.03% | 218 |
|
|
2023
Q3 | $25.9K | Buy |
1,782
+880
| +98% | +$12.8K | 0.01% | 282 |
|
|
2023
Q2 | $18.9K | Sell |
902
-26
| -3% | -$544 | 0.01% | 274 |
|
|
2023
Q1 | $19.6K | Buy |
928
+316
| +52% | +$6.67K | 0.01% | 224 |
|
|
2022
Q4 | $15.6K | Buy |
612
+82
| +15% | +$2.09K | 0.01% | 192 |
|
|
2022
Q3 | $13K | Buy |
+530
| New | +$13K | 0.01% | 184 |
|